Don't know what part about LCY wanting nothing to do with those components is hard to comprehend ? Still waiting for any proof of value the monitor got for them . Guess it most be in those hidden fairytale documents he forgot to show the court .
As described in the Ninth Report, the Company also retained some of its contractual rights following
the Visolis Transaction, as the purchaser did not force the assignment of contracts of the Company as
part of that transaction. Notably, this includes the Company’s rights under certain development and
licensing agreements with Cargill Incorporated (“Cargill”), as well as non-assertion agreements with
Reverdia V.O.F. (“Reverdia”) and Mitsubishi Chemical Corporation (“MCC”) that permit the use of
certain intellectual property by BioAmber Inc. The Monitor is exploring options to realize value from
these rights of BioAmber Inc., but cautions that the ability to do so is subject to reaching agreement
with Cargill, Reverdia and MCC on an acceptable acquirer, and on the satisfaction of material cure
costs connected with those agreements.
16. No transactions involving the shares of the Company or its subsidiaries have occurred nor are anticipated.
Waiting for you to provide anything besides desperate spinning .
News 
Market Data 
Discover 
